# Immune Modulation With PRaG-1 Treatment

> **NCT07002502** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 19 (estimated)

## Conditions studied

- Cancer
- Solid Cancer

## Interventions

- **DRUG:** PRaG-1(cordycepin tablet)

## Key facts

- **NCT ID:** NCT07002502
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2026-05-26
- **Final completion:** 2026-06-26
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07002502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07002502, "Immune Modulation With PRaG-1 Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07002502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*